These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30721768)

  • 1. Chronic insulinopenia/hyperglycemia decreases cannabinoid CB
    Moura LIF; Lemos C; Ledent C; Carvalho E; Köfalvi A
    Brain Res Bull; 2019 Apr; 147():101-109. PubMed ID: 30721768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient gain of function of cannabinoid CB
    Pedro JR; Moura LIF; Valério-Fernandes Â; Baptista FI; Gaspar JM; Pinheiro BS; Lemos C; Kaufmann FN; Morgado C; Silva-Santos CSD; Tavares I; Ferreira SG; Carvalho E; Ambrósio AF; Cunha RA; Duarte JMN; Köfalvi A
    Brain Res Bull; 2020 Aug; 161():106-115. PubMed ID: 32428627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.
    Lin CL; Hsu YC; Lee PH; Lei CC; Wang JY; Huang YT; Wang SY; Wang FS
    J Mol Med (Berl); 2014 Jul; 92(7):779-92. PubMed ID: 24722948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
    Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
    Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
    Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach.
    Lemos C; Valério-Fernandes A; Ghisleni GC; Ferreira SG; Ledent C; de Ceballos ML; Köfalvi A
    J Neurosci Methods; 2012 Mar; 204(2):366-73. PubMed ID: 22155442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of BiP as a CB
    Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
    J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and Cannabinoid CB1 receptor deficiency promote similar early onset aging-like changes in the skin.
    C Leal E; F Moura LI; Pirzgalska RM; Marques-da-Silva D; Ledent C; Köfalvi A; Carvalho E
    Exp Gerontol; 2021 Oct; 154():111528. PubMed ID: 34437952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
    Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
    Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression.
    Schechter M; Weller A; Pittel Z; Gross M; Zimmer A; Pinhasov A
    J Neuroendocrinol; 2013 Oct; 25(10):898-909. PubMed ID: 23895426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.
    Jourdan T; Szanda G; Cinar R; Godlewski G; Holovac DJ; Park JK; Nicoloro S; Shen Y; Liu J; Rosenberg AZ; Liu Z; Czech MP; Kunos G
    Diabetes; 2017 Apr; 66(4):994-1007. PubMed ID: 28082458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.
    Wyrofsky RR; Reyes BAS; Yu D; Kirby LG; Van Bockstaele EJ
    Eur J Neurosci; 2018 Sep; 48(5):2118-2138. PubMed ID: 30103253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
    Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
    Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
    J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets.
    González-Mariscal I; Montoro RA; Doyle ME; Liu QR; Rouse M; O'Connell JF; Santa-Cruz Calvo S; Krzysik-Walker SM; Ghosh S; Carlson OD; Lehrmann E; Zhang Y; Becker KG; Chia CW; Ghosh P; Egan JM
    Diabetologia; 2018 Jun; 61(6):1470-1483. PubMed ID: 29497784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.
    Song D; Bandsma RH; Xiao C; Xi L; Shao W; Jin T; Lewis GF
    Diabetologia; 2011 May; 54(5):1181-9. PubMed ID: 21340622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
    Giné E; Echeverry-Alzate V; Lopez-Moreno JA; Rodriguez de Fonseca F; Perez-Castillo A; Santos A
    Neuropharmacology; 2017 Apr; 116():132-141. PubMed ID: 28017790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.